OXALIPLATIN
Generic: OXALIPLATIN
Meitheal Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
OXALIPLATINActive Substance
2024-01-11Original Approval
OXALIPLATIN is FDA application ANDA217348, sponsored by MEITHEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
6,869 reports
2
NAUSEA
5,479 reports
3
OFF LABEL USE
4,668 reports
4
VOMITING
4,414 reports
5
NEUROPATHY PERIPHERAL
4,317 reports
6
DISEASE PROGRESSION
4,313 reports
7
NEUTROPENIA
4,206 reports
8
THROMBOCYTOPENIA
3,524 reports
9
DYSPNOEA
3,084 reports
10
PYREXIA
2,869 reports